One in three men will experience moderate to severe lower urinary tract symptoms in their lifetime, with symptoms including ...
Federal officials may remove warnings on testosterone therapy drugs about heart and prostate risks, which could expand access ...
A urologist at the Fox Chase-Temple Urologic Institute explains the options and warns that ignoring an enlarged prostate ...
Morning Overview on MSN
Capivasertib won FDA approval for a hard-to-treat form of prostate cancer
Men diagnosed with metastatic prostate cancer that lacks the PTEN protein now have a targeted drug option for the first time.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results